Utah Medical Products (UTMD) Return on Capital Employed (2011 - 2026)
Utah Medical Products (UTMD) posted quarterly Return on Capital Employed of 9.01% for Q1 2026, down 187.0% year-over-year from 10.36% in Q1 2025, and down 5.39% quarter-over-quarter from 9.53% in Q4 2025.
Utah Medical Products (UTMD) Return on Capital Employed (2011 - 2026) Analysis & Trends
Utah Medical Products' Return on Capital Employed history runs 16 years deep, the most recent figure standing at 9.01% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 187.0% year-over-year to 9.01%; the TTM figure through Mar 2026 stood at 9.01% (down 187.0% YoY), while the FY2025 annual figure was 9.51%, down 135.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 9.01%, down from 9.53% in the prior quarter.
- The five-year high for Return on Capital Employed was 17.88% in Q3 2022, with the low at 9.01% in Q1 2026.
- The 5-year median for Return on Capital Employed is 12.48% (2024), against an average of 13.3%.
- The sharpest annual moves came in 2022 and 2023: Return on Capital Employed surged 483 bps in 2022, then tumbled 414 bps in 2023.
- Utah Medical Products' Return on Capital Employed stood at 17.18% in 2022, then dropped by 24 bps to 13.04% in 2023, then retreated by 15 bps to 11.11% in 2024, then dropped by 14 bps to 9.53% in 2025, then dropped by 5 bps to 9.01% in 2026.
- Business Quant data shows UTMD's Return on Capital Employed at 9.01% in Q1 2026, 9.53% in Q4 2025, and 10.04% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 18.58% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 6.00% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 28.11% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 25.22% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 5.57% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 19.71% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 19.76% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 4.68% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 3.28% |
| 10 | Utah Medical Products | 227.50 Mn | 139.97 Mn | 4.76 Mn | 8.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.39% |
| Mar 31, 2026 | 9.01% |
| Dec 31, 2025 | 9.53% |
| Sep 30, 2025 | 10.04% |
| Jun 30, 2025 | 10.57% |
| Mar 31, 2025 | 10.88% |
| Dec 31, 2024 | 11.11% |
| Sep 30, 2024 | 11.55% |
| Jun 30, 2024 | 11.83% |
| Mar 31, 2024 | 12.48% |
| Dec 31, 2023 | 13.04% |
| Sep 30, 2023 | 14.13% |
| Jun 30, 2023 | 15.39% |
| Mar 31, 2023 | 16.46% |
| Dec 31, 2022 | 17.18% |
| Sep 30, 2022 | 17.88% |
| Jun 30, 2022 | 17.45% |
| Mar 31, 2022 | 17.48% |
| Dec 31, 2021 | 16.57% |
| Sep 30, 2021 | 15.92% |